
ÕÅÀÚ
ÉîÛÚÌì˸ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾¶Ê³¤
ΰÒײ©MBA2017¼¶ÔÚÖ°°à
±àÕßµ¼Óï
Äõ½ÕÅÀÚ¼òÀúµÄʱ¼ä£¬±»ºóÃæ¸½ÉϵĽÒÏþÎÄÏ×¼°Ñо¿ÀÖ³ÉÏÅÁËÒ»Ìø¡£Ì¹³ÏµÄ˵£¬²¢Ã»Ïëµ½MBAµÄѧÉú»áÓÐÔÆÔÆ·á¸»µÄ¡¢´¿´âµÄѧÊõÐÔÑо¿Ð§¹û¡£Ò»Ê±ºÃÆæÐÄÖèÆð£ºÎªÊ²Ã´ÕâÑùÅä¾°µÄҽѧÉúҪѡÔñ±±´óΰÒײ©MBAÄØ£¿ËûÓÐ×ÅÔõÑùµÄÀíÏëÓë¹ÊÊ£¿ÈÃÎÒÃÇÒ»ÆðÀ´½ÒÏþ°É~
01
ÄÜ·ñÏÈΪ¸÷È˼òÆÓÏÈÈÝÒ»ÏÂ×Ô¼º£¿
ÎÒ³öÉúÓÚÒ½Éú¼ÒÍ¥£¬Ò»¾ÔÚÉîÛÚÊжùͯҽԺ´Óʶù¿ÆÁÙ´²ÊÂÇ飬2008ÄêÓÚÏã¸ÛÖÐÎÄ´óѧȡµÃ²©Ê¿Ñ§Î»ºó½øÈ뻪´ó»ùÒò´ÓÊ»ùÒò×éѧÊÖÒÕµÄÁÙ´²×ª»¯ºÍÍÆ¹ã£¬Ö®ºóÔÚ¸´ÐÇÆìϵÄÑÇÄÜÉúÎï´ÓÊÂҽѧºÍBDÊÂÇé¡£2018Ä꣬ÎÒ¿ª°ìÁËÉîÛÚÌì˸ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾£¬×¨×¢¾ÙÐÐÖ×ÁöÒºÌå»î¼ìÊÖÒÕµÄÑз¢¡¢×ª»¯ºÍÍÆ¹ã¡£
*ÕÅÀÚÑо¿Ïà¹Ø¼Í¼
Ó¢ÎIJ¿·Ö
[1] Qunxian Rao*, Qian Zhang*, Chunhong Zheng, Wenjun Dai,
Bingzhong Zhang, Cristian Ionescu-Zanetti,Zhongqiu Lin, Lei Zhang. Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system. Int J Clin Exp Pathol 2017;10(9):9599-9606.
[2] Zhang L, Tang J, Haines CJ, Feng H, Teng X, Han Y. RA induces differentiation of multipotent P19 cells towards male germ cell. In Vitro Cell Dev Biol Anim. 2015. 51(1): 85-91.
[3] Sun L*, Zhang L*, Zhou J, et al. Noninvasive prenatal testing for fetal trisomy 9 mosaicism by maternal plasma DNA sequencing[J]. Case Reports in Perinatal Medicine, 2015, 4(1): 37-40. (*contribute equally as first authors)
[5] Zhang L, Tang J, Haines CJ, et al. c-kit expression profile and regulatory factors during spermatogonial stem cell differentiation. BMC Dev Biol, 2013,13(1):38.
[6] Zhang L, Tang J, Haines CJ, Feng HL, Lai L, Teng X, Han Y. c-kit and its related genes in spermatogonial differentiation. Spermatogenesis, 2011,1(3):186-194.
[7] Choi H, Lau TK, Jiang FM, Chan MK, Zhang HY, Lo PS, Chen F, Zhang L, Wang W. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'False positive' due to confined placental mosaicism. Prenat Diagn, 2013 Feb;33(2):198-200
[8] Chen S, Ge H, Wang X, Pan X, Yao X, Li X, Zhang C, Chen F, Jiang F, Li P, Jiang H, Zheng H, Zhang L, Wang W, Li S, Wang J, Yang H, Li Y, Zhang X. Haplotype-assisted accurate noninvasive fetal whole genome recovery through maternal plasma sequencing. Genome Med. 2013. 5(2): 18.
[9] Chen S, Lau TK, Zhang C, Xu C, Xu Z, Hu P, Xu J, Huang H, Pan L, Jiang F, Chen F, Pan X, Xie W, Liu P, Li X, Zhang L, Li S, Li Y, Xu X, Wang W, Wang J, Jiang H, Zhang X. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn. 2013. 33(6): 584-90.
[10] Yao H, Zhang L, Zhang H, Jiang F, Hu H, Chen F, Jiang H, Mu F, Zhao L, Liang Z, Wang W. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn, 2012,32(11):1114-6.
[11] Chan KY, Xiang P, Zhou L, Li K, Ng PC, Wang CC,Zhang L, Deng HY, Pong NH, Zhao H, Chan WY, Sung RY. Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks. Eur J Heart Fail, 2011,13(4):366-76.
[12] Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Ng PC, Pong NH, Zhao H, Zhang L, Sung RY. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol, 2009,63(2):343-9.
ÖÐÎIJ¿·Ö
[1] ÕÅÀÚ, ÓÚ½à. ¶ùͯ¼±ÐÔ°×Ѫ²¡¼°¶ñÐÔÁܰÍÁöµÄ°ÐÏòÖÎÁÆ. ÖйúÑÖ¤¶ù¿ÆÔÓÖ¾, 2006,1(3):215-222.
[2] ÕÅÀÚ, ÓÚ½à, Īæ, µÈ. Fn¡¢TPO»ùÒòÐÞÊζÔÈ˹ÇËè¼ä³äÖʸÉϸ°ûµÄÓ°Ïì. ÖлªÑªÒºÑ§ÔÓÖ¾, 2007,28(12):832-836.
[3] ÕÅÀÚ, ÓÚ½à, Īæ, µÈ. FN-TPO»ùÒòÐÞÊεĹÇËè¼ä³äÖʸÉϸ°ûÖ§³ÖÆêѪÔìѪ¸Éϸ°ûÖ²ÈëµÄʵÑéÑо¿. ÖйúÊäѪÔÓÖ¾, 2009,(02):94-98.
[4] ÕÅÀÚ£¬ÍõÍþ. ÎÞ´´²úǰ»ùÒò¼ì²âÌ¥¶ùȾɫÌå·ÇÕû±¶ÌåÊÖÒÕÑо¿¼°Ó¦ÓÃÏ£Íû. Öйú²úǰÕï¶ÏÔÓÖ¾£¬2012,4(3):32-40.
[5] ÓÚ½à, ÕÅÀÚ, Īæ, µÈ. Äæ×ªÂ¼²¡¶¾ÔØÌå½éµ¼Fn-TPO»ùÒòÐÞÊÎÈ˹ÇËè¼ä³äÖʸÉϸ°û. µÚÈý¾üÒ½´óѧѧ±¨, 2006,28(24):2396-2399.
[6] Īæ, ÓÚ½à, ÑîĬ, ÀîÖ¾¹â, Àî¹ðϼ, ÕÅÀÚ. µ±¹é¶àÌÇÓëѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÑªÐ¡°åÌìÉúËØ¶Ô¾ÞºËϸ°ûÔìѪӰÏìµÄ½ÏÁ¿Ñо¿. Öлª¶ù¿ÆÔÓÖ¾. 2008. 46(1): 45-48.
[7] ÎâÑÞ, ÓÚ½à, ÕÅÀÚ£¬µÈ. ÔÙÉúÕϰÐÔѪÐ黼¶ù¹ÇËè¼ä³äÖʸÉϸ°ûÌåÍâÔìѪ֧³Ö×÷ÓõÄÑо¿. Öйú½ñÊÀ¶ù¿ÆÔÓÖ¾. 2008. 10 (4): 455-459.
[8] ÎâÑÞ, ÓÚ½à, ÕÅÀÚµÈ. ÔÙÉúÕϰÐÔѪÐ黼¶ù¹ÇËè¼ä³äÖʸÉϸ°ûÃâÒßµ÷Àí×÷ÓõÄÑо¿. ÖйúÊÊÓöù¿ÆÔÓÖ¾. 2009. (10): 786-790.
[9] ÎâÑÞ, ÓÚ½à, ÕÅÀÚ, µÈ. ÌØ·¢ÐÔѪС°åïÔÌÐÔ×Ïñ°»¼¶ù¹ÇËèMSC TGF-¦Â1ºÍHGFµÄ±í´ï¼°¶ÔÃâÒߵĵ÷Àí×÷ÓõÄÑо¿. ÖØÇìÒ½¿Æ´óѧѧ±¨, 2009,34(3):260-264.
[10] Ò¦ÐãÔÆ, ÕÅÓåÃÀ, ÇØÝè×Ó£¬²ýÊ¢£¬×ÞÁÕ£¬³ÂÊËÆ½£¬ÕÅÀÚ£¬Ð»Ü磬ÖÓÏþÜ¿. ÖØÇìÊкº×å¶ùͯ¦Â-µØÖк£ÑªÐéµÄ·Ö×ÓÊ¢Ðв¡Ñ§Ñо¿. Öлª¶ù¿ÆÔÓÖ¾, 2013,51(7):518-522.
[11] ÔøÔÆ, ·ë´ó·É, ÕÅÀÚ, µÈ. ÏßÁ£ÌåMT-RNR1»ùÒòÍ»±äÓëÒ©ÎïÐÔÁû. ÌýÁ¦Ñ§¼°ÑÔÓï¼²²¡ÔÓÖ¾, 2013,(04):428-430.
[12] ÓÚ½à, ÏÜÓ¨, Ò¦ÐãÔÆ£¬Ð¤½£ÎÄ£¬Áõº£Ñ࣬³ÂÊËÆ½£¬ÕÅÀÚ£¬ÕÅÓåÃÀ£¬ÇØÝè×Ó. ÖØÇìÊÐѧÁäǰ¶ùͯ¦ÁµØÖк£ÑªÐéµÄ·Ö×ÓÊ¢Ðв¡Ñ§Ñо¿. ÖлªÑªÒºÑ§ÔÓÖ¾. 2014. 35(5): 419-423.
[13] Ðí¾ü, ҶСÀÚ, ³ÂÊç·É£¬Ö£ÖÜÊý£¬ÉÛС·É£¬ËÕÈʽܣ¬ÕÅÀÚ£¬ÔøÔÆ£¬Ê·²¨Äþ. ÏÈÌìÐÔ·Ç×ÛºÏÕ÷ÐÔ¶úÁû»¼Õß100Àý³£¼û¶úÁû»ùÒòÆÊÎö. ÖйúÑÛ¶ú±Çºí¿ÆÔÓÖ¾. 2014. (03): 184-186.
[14] ÕÅÀÚ, »Æ»ÛÁá, Ñî°º, Ñî°º, Ö£´ººì, ÖìÓñ»ª, ÁõËÉ÷ë, ÀîÓ¡Êç. ÃâÒß´ÅÖé·¨ÒõÐÔ¸»¼¯Ñ»·Ö×Áöϸ°ûÒªÁìµÄ½¨Éè. Ä¥Á·Ò½Ñ§. 2018,33 (8): 770-771.
Ö÷³Ö»ò¼ÓÈë¿ÎÌâ
[1] ÉîÛÚҺ̬»î¼ìÖ×Áö¸öÐÔ»¯Õï¶ÏÊÖÒÕ¹«¹²Ð§ÀÍÆ½Ì¨£¨Éî·¢¸Ä[2016] 887ºÅÎļþ£©£¬ÉîÛÚÊÐÉú³¤Ë¢ÐÂίսÂÔÐÔÐÂÐ˹¤ÒµºÍδÀ´¹¤ÒµÉú³¤×¨Ïî×ʽð£¬×ÊÖú¶î¶È500Íò£¬ÏîÄ¿ÈÏÕæÈË¡£
[2] Ñ»·Ö×Áöϸ°û¼ì²âÊÖÒÕ¿ª·¢¼°ÔÚÂѳ²°©ÕïÁÆÖеÄÓ¦Óã¨KQCX2015033016451172£©£¬ÉîÛÚÊÐÍâÑó¸ßÌõÀíÈ˲ÅÁ¢Ò촴ҵרÏî×ʽð£¬×ÊÖú¶î¶È80Íò£¬ÏîÄ¿ÈÏÕæÈË¡£
[3] »ùÖÊϸ°ûºÍMSCµÄ»ùÒòÐÞÊζÔÔìѪϸ°ûÀ©Ôö¼°ÔìÑªÖØÐÞµÄÓ°Ïì £¨30100095) ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð×ÊÖúÏîÄ¿£¬×ÊÖú¶î¶È17Íò£¬¼ÓÈë¡£
[4] ¾«Ôϸ°û·Ö½âµÄ»ùÒò±í´ï¼°µ÷¿Ø Hong Kong RGC grant (2140638)£¬×ÊÖú¶î¶È80Íò¸Û±Ò£¬¼ÓÈë¡£
02
ÔÚ¼òÀúÖп´µ½ÄãµÄѧÊõÑо¿Ð§¹ûÊ®·Ö·á¸»£¬ÄÜ·ñΪÎÒÃÇÏÈÈÝһϣ¿
ÔÚÒÑÍùµÄÊ®ÓàÄêÖУ¬ÎÒÖ÷ÒªÔÚ»ùÒòºÍϸ°ûÁ½¸öÆ«Ïò¾ÙÐÐÁËһЩ̽Ë÷£¬³Ðµ£»ò¼ÓÈë¹ý¹ú¼Ò¡¢Ê¡¡¢Êи÷¼¶¿Æ¼¼ÏîÄ¿Èô¸ÉÏÔÚº£ÄÚÍâÆÚ¿¯½ÒÏþÁ˶þÊ®ÓàÆªÑ§ÊõÂÛÎÄ£¬È¡µÃÁËÒ»µãЧ¹û£¬µ«ÈÔÐèÒª¼ÌÐøÆð¾¢¡£ÔÚ»ùÒòÁìÓò£¬ÎÒºÜÊÇÐÒÔ˵ÄÔÚÎÞ´´²úǰ»ùÒò¼ì²â£¨NIPT£©ÏîÄ¿ÁÙ´²×ª»¯ºÍÍÆ¹ã×îÖ÷ÒªµÄ½×¶Î¼ÓÈëÆäÖв¢ÈÏÕæÒ½Ñ§ÊÂÎñ£¬Õâ¸öÏîÄ¿ÒѾÔÚÈ«Çò¹æÄ£ÄÚ»ñµÃÆÕ±éÓ¦Ó㬹ØÓÚÔ¤·ÀÌÆÊÏ×ÛºÏÕ÷µÈÑÏÖØ³öÉúȱÏݵı¬·¢Æðµ½Á˺ܺõÄ×÷Óã¬ÎªÐí¶à¼ÒÍ¥×èÖ¹Á˱¯¾çµÄ±¬·¢£¬Í¬Ê±Ò²ÎªÈ«Éç»á½ÚÔ¼ÁË´ó×ÚµÄÒ½ÁÆ×ÊÔ´¡£Î´À´£¬Ð¡ÎÒ˽¼ÒÒÔΪÓиü´óҽѧ¼ÛÖµºÍÊг¡¿Õ¼äµÄÏîĿӦ¸Ã³ö×Ôϸ°ûÁìÓò£¬ÓÉÓÚ²»¹ÜÊÇÄĸö·Ö×Ó²ãÃæµÄ¸Ä±ä×îÖÕ¶¼ÐèÒªÓ°Ïìϸ°ûµÄ¹¦Ð§¶øµ¼Ö¼²²¡±¬·¢¡£Î´À´ÈýÊ®Äê£¬Ëæ×ÅÎÒ¹úÀÏÁ仯µÄÒ»Ö±¼Ó¾çºÍÔ¤ÆÚÈ˾ùÊÙÃüµÄÒ»Ö±Ìá¸ß£¬ÒÔ°©Ö¢¡¢ÐÄÄÔѪ¹Ü¼²²¡ºÍÌÇÄò²¡Îª´ú±íµÄÂýÐÔ²¡µÄ·¢²¡ÂÊÒ»¶¨ÖðÄêÉý¸ß£¬¶øÈËÀà¶ÔÕâЩ¼²²¡µÄÊìϤ»¹²»Í¸³¹£¬ÒÔÊÇ»ùÓÚϸ°û²ãÃæµÄÑо¿ºÍҽѧӦÓÃÒ»¶¨´óÓпÉΪ¡£
03
ÄãÔÚÊÂÇéǰÆÚÒ»Ö±óÆÖ¾Ñ§ÊõÑо¿ÒÔ¼°ÁÙ´²Ò½Ñ§£¬µ«½ü¼¸ÄêÏòÉÌÒµ»¯µÄÆ«Ïò¾ÙÐÐÁËת±ä£¬ÄÜ·ñΪÎÒÃÇ·ÖÏíÒ»ÏÂÄãµÄÆðµã£¿
»òÐíÊÇÓÉÓÚҽѧÅä¾°µÄÉíÊÀ£¬Ïà±È»ù´¡Ñо¿£¬ÎÒ¸üϲ»¶Ó¦ÓÃÑо¿»òÕßת»¯Ñо¿¡£ÎÒµÄÈËÉúÔ¶¾°£¬ÊÇÖúÁ¦ÁÙ´²¡¢Ô츣¹«¹²£¬½«È«Çò×îÏȽøµÄ¿ÆÑÐЧ¹ûת»¯³ÉÁÙ´²¿ÉÓõÄÊÖÒպͲúÆ·£¬Íƶ¯ÎÒ¹ú¿µ½¡ÊÂÒµÉú³¤¡£¶àÄêǰ£¬ÔÚÎÒ¸Õ¸Õ½øÈëÒ½Ôº£¬×îÏÈ´ÓÊÂÁÙ´²ÊÂÇéµÄʱ¼ä£¬ÎÒÔøÔÚÐÄÖиø×Ô¼ºËã¹ýÒ»±Ê¼òÆÓµÄÕÊ£º×÷ΪһÃûÁÙ´²Ò½Éú£¬ÈôÊÇÎÒÌìÌìЧÀÍÒ»°Ùλ»¼Õߣ¬Ò»ÄêËêÇéÈý°ÙÌ죬ÄÇô×î¶àЧÀÍÈýÍòÃû»¼Õߣ¬ÍËÐÝǰÊÂÇéÈýÊ®Ä꣬×î¶à¿ÉÒÔЧÀ;ÅÊ®ÍòÃû»¼Õߣ»¶øÈôÊÇÎÒת»¯ÀÖ³ÉÒ»¸öÏîÄ¿£¬Ò»ÄêЧÀ͵ϼÕßÊýÄ¿¾ÍÔ¶Ô¶²»Ö¹¾ÅÊ®Íò¡£Ä¿µÄÒѾ¶¨Ï£¬Ê£ÏµľÍÊÇÔõÑùʵÏÖ¡£È»¶ø£¬×öѧÊõºÍ×ö²úÆ·£¨ÉÌÒµ£©ÊÇÁ½ÂëÊ£¬¶ÔÎÒµÄÌôÕ½Ò²ÊÇÈ«·½Î»µÄ£¬È»¶øÎÞÂÛÓöµ½Ê²Ã´ÑùµÄÄÑÌ⣬ËÈËÎôʱ¿´ÆðÀ´ÓÐЩÖÉ×ÓµÄËãÊõÌâÕâô¶àÄêÀ´Ò»Ö±Íƶ¯ÎÒһֱǰ½ø£¬²»´ïÄ¿µÄ²»ÈöÊÖ£¡

04
ÄãÒÔΪÄãµÄÖ°Òµ×·ÇóÊÇ·ñÊܵ½±±´óµÄ¼Ò¹úÇ黳ӰÏ죿Ϊʲô×îÖÕÑ¡ÔñÁË´´Òµ£¿
±±´óµÄÏȽøÃÇΪÖлªÃñ×åµÄΰ´óÔÙÆð×ö³öÁ˲»¿ÉÏûÊŵÄТ˳£¬ËûÃÇÊÇÎÒ½ñÉúѧϰµÄ¿¬Ä£¡£´´Òµ¹ØÓÚÎÒÀ´Ëµ²»ÊÇÄ¿µÄ£¬ËüÖ»ÊÇÒ»¸öÀú³Ì¡¢Ò»ÖÖÄ¥Á·¡£Ñ¡Ôñ´´ÒµÊÇΪÁ˸üºÃµÄÍÆ¶¯ÏîÄ¿µÄÏ£Íû£¬Ï£Íûͨ¹ýÈô¸ÉÄ겻иµÄÆð¾¢£¬Äܹ»ÔÚ»ù´¡Ñо¿ÓëÁÙ´²Ò½Ñ§¼ä¼ÜÉèÆðÒ»×ùÇÅÁº£¬½«ÓÅÒìµÄ»ù´¡Ñо¿Ð§¹û¿ìËÙת»¯³ÉÉú²úÁ¦¡£
05
ͨË×ÈËÒ»Ñùƽ³£ÊÇÖð¼¶ÏòÉÏÐÞϰѧ룬¶øÄãÔÚÍê³É²©Ê¿Ñ§Î»ºó£¬ÄæÁ÷¶øÐоͶÁMBA£¬ÄãΪʲô×öÕâÑùµÄÑ¡Ôñ£¿
ѧλÓÐÆéá«£¬µ«Ñ§Ï°ºÍ֪ʶûÓиßÏÂÖ®·Ö¡£ËäÈ»ÎÒÔÚҽѧÁìÓòѧϰ¡¢Ñо¿Á˶àÄ꣬Ҳ»ñµÃÁ˲©Ê¿Ñ§Î»£¬µ«Ê¼ÖÕÒÔΪ×Ô¼ºµÄÖªÊ¶Ãæ»¹½ÏÁ¿Õ£¬²»¿ÉÖª×ã×÷ΪһÃû´´ÒµÕßµÄÒªÇó¡£Òò´Ë£¬ÔÚÕýʽ̤ÉÏ´´ÒµÂ·Ö®Ç°£¬ÎÒÏ£ÍûÄÜϵͳµÄÏàʶ¹ØÓÚÆóÒµÔËÓªµÄÏà¹ØÖªÊ¶£¬¶øMBAµÄ¿Î³ÌÉèÖÃǡǡºÜºÃµÄÖª×ãÁËÎÒµÄÐèÇó£¬ÒÔÊǶÁMBA¶ÔÎÒÀ´Ëµ¾ÍÊÇÒ»ÖÖѧϰ·½·¨£¬²»±£´æË³Á÷¡¢ÄæÁ÷¡£
06
´ÓÒ½Éú¡¢Ñ§ÕߵĽÇÉ«Çл»µ½ÉÌÈ˺ʹ´ÒµÕߣ¬ÆäÖÐÓöµ½¹ýÄÄЩÄÑÌâ»òÖÊÒÉÂð£¿
Ò½Éú¡¢Ñ§ÕßÓëÉÌÈË¡¢´´ÒµÕß¼äµÄ²î±ðÖØ´ó¡£Ò½Éú¡¢Ñ§ÕßµÄÊÂÇéÐÔ×ÓÖ÷ÒªÊÇÊÖÒÕÐÔÊÂÇé£¬ÃæÁÙµÄÎÊÌâÒ²¶àÊǿ͹۵ġ¢È·¶¨ÐԵģ»¶øÉÌÈË¡¢´´ÒµÕßµÄÊÂÇéÐÔ×ÓÔ½·¢¶àÔª»¯£¬Ö÷¿Í¹Û¶¼ÓУ¬²»È·¶¨ÐԺܸߡ£Òò´Ë£¬´´ÒµÖ®³õ£¬ÓÉÏà¶ÔÈ·¶¨ÐÔµÄÊÂÇéת±äΪ¸ß¶È²»È·¶¨ÐÔµÄÊÂÇ飬¶ÔÎҵĹ¥»÷ºÜ´ó£¬ËùÐÒ¾Óɵ÷½â£¬ÎÒÒѾÖð½¥Ë³Ó¦ÁËÕâÖÖÊÂÇé·½·¨¡£Ð¡ÎÒ˽¼ÒÒÔΪ£¬¹ØÓÚ´´ÒµÕßÀ´Ëµ×îÖ÷ÒªµÄÊÇÍŶӡ¢×ʽðºÍÐÄ̬£¬ÕâÈý¸ö·½ÃæÓÈÒÔÐÄ̬×îΪÖ÷Òª£¬¾ø´ó´ó¶¼´´ÒµÏîÄ¿¶¼ÊÇÔÚ×ÊÔ´ºÜÊÇÓÐÏÞµÄÇéÐÎÏÂͨ¹ýÆ´ÃüÆð¾¢²Å»ªÉú³¤ÆðÀ´µÄ£¬µ±ÀíÏëÔâÓöÏÖʵ£¬¼á³ÖÓÅÒìµÄÐÄ̬£¬²»Íü³õÐÄ£¬½«´óÄ¿µÄÆÊÎö³ÉÒ»¸ö¸ö½×¶ÎÐÔµÄСĿµÄ£¬²¢ÇÒÖð¸ö¸æ¿¢£¬ÏòÄ¿µÄÂõ½øµÄ³ÌÐòÀúÀ´¶¼²»ÅÂС¡£
07
±±´óΰÒײ©MBAµÄ¿Î³ÌÊÇ·ñ¸øÄãµÄÊÂÒµ´øÈ¥ÖúÁ¦£¿¶ÔÄãµÄÈËÉúÓÐʲôÆô·¢£¿
±±´óΰÒײ©MBA¿Î³Ì¸øÎÒµÄÊÂÒµ´øÀ´ºÜ´óÖúÁ¦¡£±±´óΰÒײ©ÖÎÀíѧԺÊǺ£ÄÚ×îÔ罨ÉèµÄÖÎÀíѧԺ֮һ£¬¡°´´Á¢ÖÎÀí֪ʶ£¬×÷ÓýÉ̽çÊ×ÄÔ£¬Íƶ¯Éç»áǰ½ø¡±ÊÇΰÒײ©ÖÎÀíѧԺµÄʹÃü£¬Î°Òײ©MBA¿Î³Ì¾ùÓÉÓµÓвî±ðѧÊõÅä¾°ºÍÂÄÀú¡¢ÔÚ¹ú¼ÊÉÏÓнϸß×ÅÃû¶ÈµÄ½ÌÊÚÈν̡£¿Î³ÌÄÚÈݼÈÓи»ºñµÄѧÊõÀíÂÛ֪ʶ£¬ÓÖÓдó×Úʵ²ÙÐԵݸÀý£¬ÀíÂÛºÍʵ¼ùÍŽᣬÈÃÎÒ»ñµÃÁË´ó×ÚҽѧרҵÒÔÍâµÄ¶Ô´´ÒµÓÖÖÁ¹ØÖ÷ÒªµÄ֪ʶ¡£³ý¿ÎÌÃÉϵÄ֪ʶÍ⣬½ÌÊÚÃÇÕë¶ÔÏêϸµÄ´´ÒµÏîÄ¿»¹»á´Ó²î±ðµÄ½Ç¶È¸ø³ö½¨ÒéÒÔ¼¿ÕÊÖú¶Ô½ÓÖÖÖÖ×ÊÔ´¡£ÁíÍ⣬±±´óΰÒײ©MBAͬÑâ¾ùÊÇÀ´×Ô¸÷Ðи÷ÒµµÄ¾«Ó¢£¬ÓëͬÑâÃǵĽ»Á÷Ò²¼«´óÁË̹µ´ÁËÎÒµÄ˼Ð÷£¬ÈÃÎÒ»ñÒæ·Ëdz¡£±ðµÄ£¬±±´óΰÒײ©MBAÉÐÓÐÒ쳣ǿʢµÄУÓÑȺ£¬¸»ºñµÄУÓÑÔ˶¯Í¬Ñù¸ø´¦ÓÚ´´ÒµÆð²½½×¶ÎµÄÎÒ´øÀ´ºÜ´óÖúÁ¦¡£
08
´ó´ó¶¼MBAͬÑâµÄÅä¾°¶¼ÊǽðÈÚ¡¢IT»¥ÁªÍøÒÔ¼°ÆäËû¹¤ÒµÏà¹Ø£¬Äã×÷ΪÁÙ´²Ò½Ñ§ÕâÑùµÄѧÊõÐÔÅä¾°¼ÓÈëΰÒײ©MBA¸÷ÈËÍ¥ÒÔºó£¬ÓÐÔõÑùµÄ¹¥»÷¡¢ÊÕ»ñ¡¢¿ìÀÖ»òÄÑÌâÄØ£¿
̸²»Éϱ£´æ¹¥»÷ºÍÄÑÌ⣬µ«ÊÕ»ñºÜÊÇ´ó£¬Óë²î±ðÐÐÒµµÄͬÑâÒ»Æðѧϰ¡¢Ò»ÆðÌÖÂÛ£¬ÈÃÎÒÓú·¢ÊìϤµ½ÖªÊ¶µÄÖڶ࣬һСÎÒ˽¼ÒÔÙ²©Ñ§ËûËùÄÜÕÆÎÕµÄ֪ʶºÍÊÖÒÕÒ²ÓÐÒ»¶¨ÏÞ¶È£¬Ö»ÓÐÓëÆäËûÓÅÒìµÄÈËÒ»Æð×é³ÉÍŶӡ¢Ï໥ÅäºÏ²Å»ªÈ¡µÃ¸ü´óµÄÀֳɡ£

09
ÓÐʲô¼ÄÓïÏëË͸ø2020ÄêµÄÉêÇëÕßÂð£¿
½ö½ö»¨Á½Äêʱ¼ä£¬ÄÜÈÃÄã»ñȡѰ³£Èô¸ÉÄê²Å»ª»ñµÃµÄ֪ʶºÍÊÖÒÕ£¬µ½±±´óΰÒײ©¶ÁMBAÒ»¶¨ÊÇÒ»±ÊºÜ»®ËãµÄͶ×Ê¡£
10
¿ìËٻظ²×îºóÒ»¸öÎÊÌ⣬ÈôÊÇÄãÒªÔÚÃìÎÞÈËÑ̵Ļĵº´ô7Ì죬ֻÄÜ´ø5¼þ¹¤¾ß£¬Äã»á´øÊ²Ã´£¿
×ã¹»µÄʳÎï¡¢µË®¡¢Ò©Æ·£¬Çå¾²·À»¤¹¤¾ßºÍÌ«ÑôÄÜÎÀÐǵ绰¡£
±àÕß½áÓï
ÀíÏëÖ÷ÒåºÍ¼Ò¹úÇ黳£¬ÊDZ±´óѧ×ÓÓбðÓÚËûÈ˵ÄÌØÉ«Ö®Ò»£¬ÔÚ²¿·ÖÈËÑÛÖУ¬Õâ»òÐíÊÇÒ»ÖÖ¡°ÖÉ×Ó¡±¡£µ«ÎÒÐÅÍУ¬Ç¡Ç¡ÊÇÕâÑùµÄ¡°ÖÉ×Ó¡±£¬²Å»ªÈÃÕÅÀÚÔÚÒ½Éú¡¢Ñ§ÕßÓëÉÌÈË¡¢´´ÒµÕß¼äÕâÑù²î±ðÖØ´óµÄ½ÇÉ«Çл»Ö®¼ä¼á³Ö±¾Õ棬²»Íü³õÐÄ¡£Ã»ÓлªÃÀµÄ´ÇÔ壬ֻÓÐÖÊÆÓµÄ³ÂÊö£¬ÕâÊÇËûµÄ¹ÊÊ£¬ÊÇÐí¶àÄ»ºóÊÂÇéÕߵĹÊÊ¡£
ΰÒײ©MBAÏîÄ¿
ΰÒײ©MBAÏîÄ¿ÖÂÁ¦ÓÚ×÷Óý¾ßÓÐÉç»áÔðÈθкÍÈ«ÇòÊÓÒ°µÄ¸ß¼¶ÖÎÀíÕßÓëδÀ´ÉÌÒµÊ×ÄÔ¡£Î°Òײ©ÖÎÀíѧԺMBAÏîÄ¿¼á³ÖÒÔ¡°´´Á¢ÖÎÀí֪ʶ£¬×÷ÓýÉ̽çÊ×ÄÔ£¬Íƶ¯Éç»áǰ½ø¡±ÎªÊ¹Ãü£¬Æð¾¢´òÔ츻ÓÐÈËÎľ«ÉñµÄMBAÏîÄ¿£¬½èÖú±±´óÉîÖ¿µÄÈËÎÄÃØÎÅ¡¢ÏµÍ³¶øÁ¢ÒìµÄ¿Î³ÌÉèÖÃÒÔ¼°¸»ºñµÄÉç»áÔ˶¯£¬Ê¹Ñ§ÉúÏàÊ¶Ç°ÑØÉÌҵ֪ʶ£¬¾ß±¸¿çÎÄ»¯Ãô¸ÐÐÔÓëÈ˼ÊÏàͬÊÖÒÕ£¬³ÉΪ¾ßÓÐÔÚÖØ´óÇéÐÎÏÂÆÊÎö½â¾öÎÊÌâÄÜÁ¦µÄ¡¢ÓÂÓڼ縺δÀ´ÌôÕ½µÄÁ¢ÒìÐÍÈ˲š£